William Finlay, based in United Kingdom, is currently a President, LockBody Program, Centessa Pharmaceuticals at Centessa Pharmaceuticals. William Finlay brings experience from previous roles at Ottimo Pharma, Granular Therapeutics Ltd, mAbs Journal and ULTRAHUMAN LIMITED. William Finlay holds a 1993 - 2001 Glasgow Caledonian University. With a robust skill set that includes Protein Engineering, Phage Display, Ribosome Display, Monoclonal Antibodies, Antibodies and more. William Finlay has 2 emails on RocketReach.
Looking for a different William Finlay?
Find contact details for 700 million professionals.